|
Gender and survival benefit from initial irinotecan in metastatic colorectal cancer: Analysis of the XELAVIRI (AIOKRK0110) study. |
|
|
No Relationships to Disclose |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; Merck Serono; Pfizer; Roche; SERVIER; Sirtex Medical |
Consulting or Advisory Role - Amgen; Bayer; Merck Serono |
Research Funding - Amgen (Inst); Merck Serono (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - Amgen; Bayer; Bristol-Myers Squibb; Merck Serono; SERVIER |
|
|
No Relationships to Disclose |
|
Ludwig Fischer von Weikersthal |
|
|
|
|
Consulting or Advisory Role - Novartis |
|
|
Consulting or Advisory Role - Abbvie; Amgen; Gilead Sciences; Hexal; Lilly; Roche |
Speakers' Bureau - Abbvie; Amgen; Boehringer Ingelheim; CSL Behring; Forum for Medical Futher Education; Gilead Sciences; Hexal; Jürgen Schaaf Verlags; Lilly; Merck Serono; Merck Sharp & Dohme; MorphoSys; Octapharm; OnkoInform; Roche; Sirtex Medical |
|
|
Honoraria - Boehringer Ingelheim; Daiichi Sankyo; Sirtex Medical |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Hexal; Merck KGaA |
Travel, Accommodations, Expenses - Amgen; Merck KGaA |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Christina Peveling genannt Reddemann |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - Roche Pharma AG |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Amgen; AstraZeneca; Biocartis; boehringer Ingelheim; Bristol-Myers Squibb; Merck KGaA; Merck KGaA; Roche; Thermo Fisher Scientific |
Speakers' Bureau - Amgen; AstraZeneca; Bristol-Myers Squibb; Roche |
|
|
Honoraria - AstraZeneca; Merck KGaA |
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck KGaA; MSD; Novartis; Pfizer; Roche |
Speakers' Bureau - AstraZeneca; Merck KGaA |
Research Funding - Merck KGaA; Roche |
|
|
Honoraria - Amgen; Bayer; Lilly; Merck KGaA; Roche; Sanofi; Sirtex Medical |
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Lilly; Merck KGaA; Roche; Sanofi; Takeda |
Travel, Accommodations, Expenses - Amgen; Bayer; Lilly; Merck KGaA; Roche; Sanofi; Sirtex Medical; Takeda |
|
|
Honoraria - Amgen; Baxalta; Boehringer Ingelheim; Celgene; Lilly; Merck; Roche; Sanofi; SERVIER; Sirtex Medical; Taiho Pharmaceutical |
Consulting or Advisory Role - Amgen; Baxalta; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Halozyme; Merck; MSD; Roche; Sanofi; SERVIER; Sirtex Medical |
Research Funding - Amgen (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Merck (Inst); Roche (Inst); Shire (Inst); Sirtex Medical (Inst) |
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; MSD; Roche; SERVIER; Shire; Sirtex Medical |